Bayer sees improvement in 2026
Bayer guided for lower earnings this year as it continues to work through a turnaround plan, but said performance is expected ...
Anderson is expecting 2025 to be a pivotal year for his turnaround plan – which revolves around the removal of management ...
1d
Zacks Investment Research on MSNBayer Q4 Earnings In Line, Revenues Top on Nubeqa, Kerendia SalesBayer AG BAYRY reported fourth-quarter 2024 core earnings of 28 cents per American Depositary Receipt (ADR), in line with the ...
While Bayer’s consumer and crop science divisions continued to slide—both in the fourth quarter and in 2024 overall—the ...
CEO Bill Anderson warned investors that profits will decline in 2025 before the company’s ongoing shake-up leads to an ...
Bayer reported Q4 adjusted EPS of $0.28, missing estimates, but sales beat forecasts. The company sees 2025 as a tough year, with growth expected from 2026.
1d
DPA International on MSNGerman chemicals group Bayer faces another difficult yearGerman pharmaceutical and agrochemical company Bayer saw profits fall again in 2024 and faces another difficult year ahead, ...
Bayer AG forecast a third straight year of falling profit as the German company struggles with mass litigation in the US, ...
Bayer's CEO is facing increasing investor pressure to deliver on turnaround efforts and reverse a forecast earnings decline ...
On an unadjusted basis, the company reported a net loss of €335mn for the fourth quarter of 2024, compared with €1.34bn net profit for the same period in 2023, and a net loss of €2.55bn for 2024, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results